Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      A Dose Escalation/Expansion Study of LDK378 in Patients With Tumors Characterized by Genetic Abnormalities in Anaplastic Lymphoma Kinase
      Description

      This study assessed the safety and efficacy of LDK378 in adult patients with genetic abnormalities in anaplastic lymphoma kinase (ALK).

      Conditions
      Tumors Characterized by Genetic Abnormalities of ALK
      Talk to us